Anatomical Discoveries
Revolutionize Prostatectomy

Surgeons Spare Nerves, Preserve Sexual Function

Jesse Green, PhD
Senior Director, Clinical Evaluation


At age 45, Robert Daly's diagnosis of prostate cancer came as a complete surprise. Of all the health problems Mr. Daly was worried about, prostate cancer was low on the list.

Suddenly, Mr. Daly faced a dilemma that thousands of men diagnosed with prostate cancer confront each year. His internist recommended surgery as the best option to cure the cancer (90% of patients with similar tumors lived at least 10 years after the surgery).


"Recognizing that radical prostatectomy
is the most effective cure for prostate cancer,
what I've been trying to do is minimize the
complications associated with the procedure."
Herbert Lepor, MD
Professor and Chairman of Urology


As a husband and father of two young children, Mr. Daly's primary concern was beating the cancer, but he was also worried about the risk of impotence and incontinence.
"I was very fearful that the surgery would affect my sexual function and bladder control," says Mr. Daly.

He was referred to Herbert Lepor, MD, a urologic surgeon at NYU Medical Center with an international reputation for performing radical prostatectomy using nerve-sparing techniques that greatly reduce the risk of complications.


Pioneering Research
Mr. Daly learned that Dr. Lepor had performed hundreds of these procedures and was one of the pioneers who, under the leadership of Patrick Walsh, MD, at Johns Hopkins, had revolutionized prostate surgery by demonstrating that it was possible to remove the prostate gland without sacrificing sexual potency.

Prior to this breakthrough, impotence invariably followed radical prostatectomy. The conventional wisdom was that this operation unavoidably caused injury to neurological or vascular pathways or both. This would severely impair normal erectile function.

A series of important clinical observations and advances in surgical technique in the late 1970s established the foundation for the nerve-sparing radical prostatectomy. Urologic surgeons had been working to reduce blood loss during prostatectomy by careful dissection and ligation of the dorsal vein complex to control bleeding. This allowed the surgery to be performed in a relatively bloodless field, in which even more meticulous dissections could be completed.

Following the surgery, younger patients began to report that they were still sexually potent, which indicated that the nerves stimulating erectile function can be preserved.

Unfortunately, a detailed anatomic description of the nerves could not be found in the literature. Preliminary anatomical research, however, confirmed that these hair-thin nerves (the cavernous nerves) were located outside the capsule of the prostate gland.

Delineating the Anatomy
A major effort was launched by Dr. Walsh to modify the procedure to avoid the cavernous nerves while maintaining adequate surgical margins. A central task, undertaken by Dr. Lepor, was the painstaking effort to accurately chart the complex anatomy encompassing the prostate. This involved dissection and three dimensional reconstruction of the adult human pelvis in minute detail to determine precisely where the microscopic cavernous nerves are located.


Many men find the prospect of lifelong impotence devastating. As a result, they may not select the most effective treatment.


Dr. Lepor and colleagues presented the new discoveries about the pelvic anatomy, the cavernous nerves, and their location at the National Meeting of the American Urological Association in 1982. This research allowed Dr. Walsh, Dr. Lepor, and colleagues to refine the surgical techniques for preserving the nerves.

Perfecting Surgical Technique
These advances made it possible to greatly reduce the rates of impotence following radical prostatectomy for patients with localized prostatic cancer. However, knowledge of the anatomy and procedures alone is insufficient. To perform this operation successfully requires a great deal of surgical experience and skill. Dr. Lepor performs over 200 radical prostatectomies at NYU Medical Center annually; his patients are usually ready to go home within two days after surgery.

Dr. Lepor's work has made it much easier for the patient to accept a recommendation of surgery. "The best chance of curing this cancer is to have the surgery, and now the operation is much safer and less traumatic than ever before," he says. "The risk of impotence is greatly reduced, and the likelihood of speedy and full recovery is extremely high." Additionally, NYU's physician-scientists are doing pioneering work in treating impotence, so even if this problem occurs, expert care is available to assist in the restoration of sexual function. A leader in this field is urologist Andrew McCullough, MD, who is investigating pharmacological and surgical therapies for erectile dysfunction.

Improvement of surgical technique in prostatectomy has led to another important benefit: reduction in incontinence. In fact, none of Dr. Lepor's patients has experienced total urinary incontinence.


Retention of Sexual Potency Depends on —
  • Extent of the cancer
  • Surgeon's skills
  • Patient's age
  • Prior state of sexual potency
  • Level of interest in sexual activity

Rapid and Full Recovery
"I was totally relieved," Mr. Daly recalls, "when I saw my wife and family, and the doctors indicated that everything went very, very well. Dr. Lepor was confident that he had spared the nerves, and he had left my lymph nodes intact."

The pathology report confirmed that Mr. Daly's cancer had been confined within the prostate gland. About two months after the operation, he was back playing four-wall handball three times a week.

"Physically, I'm in very good shape. My continence is excellent, and my sexual function returned very quickly. I really feel lucky that Dr. Lepor was able to remove all the cancer, while avoiding significant side effects.


Recent Advances in Radical Prostatectomy —
  • Reduce risk of incontinence and impotence
  • Lower risk of blood transfusion
  • Shorten hospital stay
  • Increase patient satisfaction


Advances in Treating Prostate Cancer

Herber Lepor, MD

Professor and
Chairman of Urology
NYU Medical Center




Nerve-Sparing Prostatectomy Preserves Sexual Function

"Surgical technique has been dramatically refined. We are now able to spare vital nerves and blood vessels — avoiding incontinence and speeding up recovery."

Early Diagnosis is Crucial

"Every 8 minutes a man dies in the U.S. as a result of prostate cancer. A major screening effort is underway, because if diagnosed early, there is a greater chance of cure through surgical removal of the prostate. If the cancer is still confined to the prostate, we can usually spare the nerves and minimize the side effects."

Hormone Drastically Reduces the Need for Blood Transfusion

"Prostatectomy involves loss of blood, but we pioneered the use of a natural hormone, erythropoietin, to avoid the need for transfusion. Formerly, many patients scheduled for radical prostatectomy would bank their own blood in advance of the surgery, so that they could receive an autologous transfusion when needed. Now instead, we administer the hormone weeks before surgery, to stimulate the marrow to raise the concentration of red cells."
"We studied 120 patients, randomly selected to either bank three units of blood or receive the hormone. Very few patients who received the hormone required transfusion, while most of the others needed the banked blood. Using this approach, we currently tranfuse only six percent of cases.

New Techniques can be Used to Reverse Incontinence

"For the rare prostatectomy patient with stress incontinence, NYU Medical Center is one of two centers in the U.S. studying a new technique that involves injecting silicon-like ballons around the urethra to increase bladder outflow resistance. Victor Nitti, MD, a nationally recognized authority, offers a spectrum of approaches — pharmacological and surgical — to manage incontinence."

Urology Research is the Key to Further Progress in Fighting Prostate-Related Cancers

"Like other academic institutions, the medical center is faced with eroding government funding of basic science programs. The shrinking grants can no longer fund our expanding research effort. To encourage private support, we have formed the NYU Medical Center Urology Research Program to push the frontier of treating patients with advanced disease."






For Further Information:


Webmaster: Neil Wintfeld, PhD
© Copyright 1998
Department of Clinical Evaluation and Outcomes Research
New York University Medical Center
All rights reserved.